2022 Infectious Diseases Morbidity Report

Logo

1 Introduction
2 Summary Statistics
Prevention & Control of Enteric Diseases
3 Prevention & Control of Enteric Diseases
- 3.1 Foodborne Illness Complaints
- 3.2 Notable Enteric Outbreaks and Investigations
4 Campylobacteriosis
- 4.1 Epidemiologic Review
- 4.2 Key Things to Know
5 Cryptosporidiosis
- 5.1 Epidemiologic Review
- 5.2 Key Things to Know
6 Cyclosporiasis
- 6.1 Epidemiologic Review
- 6.2 Key Things to Know
7 Giardiasis
- 7.1 Epidemiologic Review
- 7.2 Key Things to Know
8 Salmonellosis
- 8.1 Epidemiologic Review
- 8.2 Key Things to Know
9 Shiga toxin-producing Escherichia coli (STEC)
- 9.1 Epidemiologic Review
- 9.2 Key Things to Know
10 Shigellosis
- 10.1 Epidemiologic Review
- 10.2 Key Things to Know
11 Vibriosis
- 11.1 Epidemiologic Review
- 11.2 Key Things to Know
Vaccine Preventable Diseases
12 Prevention & Control of Vaccine Preventable Diseases (VPDs)
13 Chickenpox
- 13.1 Epidemiologic Review
- 13.2 Key Things to Know
14 Pertussis
- 14.1 Epidemiologic Review
- 14.2 Key Things to Know
Invasive Diseases
15 Prevention & Control of Invasive Diseases
16 Invasive Group A Streptococcus
- 16.1 Epidemiologic Review
- 16.2 Key Things to Know
17 Streptococcal Toxic Shock Syndrome (STSS)
- 17.1 Epidemiologic Review
- 17.2 Key Things to Know
18 Invasive Group B Streptococcus
- 18.1 Epidemiologic Review
- 18.2 Key Things to Know
19 Invasive Haemophilus influenzae
- 19.1 Epidemiologic Review
- 19.2 Key Things to Know
20 Invasive Streptococcus pneumoniae (SPD)
- 20.1 Epidemiologic Review
- 20.2 Key Things to Know
Sexually Transmitted Diseases
21 Prevention & Control of Sexually Transmitted Diseases
- 21.1 Prevention and Contact Tracing:
- 21.2 Current Trends and Outbreaks
22 Chlamydia
- 22.1 Epidemiologic Review
- 22.2 Key Things to Know
23 Gonorrhea
- 23.1 Epidemiologic Review
- 23.2 Key Things to Know
24 HIV, New
- 24.1 Epidemiologic Review
- 24.2 Key Things to Know
25 Early Stage Syphilis
- 25.1 Epidemiologic Review
- 25.2 Key Things to Know
Multri-Drug Resistant Organisms
26 Prevention & Control of Multi-Drug Resistant Organisms
27 Acinetobacter
- 27.1 Epidemiologic Review
- 27.2 Key Things to Know
28 E. Coli (Carbapenem Resistant)
- 28.1 Epidemiologic Review
- 28.2 Key Things to Know
29 Enterobacter (Carbapenem Resistant)
- 29.1 Epidemiologic Review
- 29.2 Key Things to Know
30 Klebsiella (Carbapenem Resistant)
- 30.1 Epidemiologic Review
- 30.2 Key Things to Know
Other Reportable Diseases
31 Other Reportable Diseases
32 Legionellosis
- 32.1 Epidemiologic Review
- 32.2 Key Things to Know
33 Coccidioidomycosis
- 33.1 Epidemiologic Review
- 33.2 Key Things to Know
34 Mpox
- 34.1 Epidemiologic Review
- 34.2 Key Things to Know
35 Active Tuberculosis
- 35.1 Epidemiologic Review
- 35.2 Key Things to Know
36 Acute Hepatitis C
- 36.1 Epidemiologic Review
- 36.2 Key Things to Know
Data Notes
37 Data Notes
Published with bookdown

2022 Infectious Diseases Morbidity Report

31 Other Reportable Diseases

The diseases in this section are not easily summarized together, so disease specific information exists for each reportable disease present in this chapter.